Mitral Regurgitation in the High-Risk Patient: Integrating an Expanding Armamentarium of Transcatheter Devices Into the Treatment Algorithm
| Autor: | Chad Kliger, Nirav Patel, Luigi Pirelli, S. Jacob Scheinerman, Joel Johnson, Carl D. Reimers, Craig Basman, Varinder Singh |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Heart Valve Prosthesis Implantation
Cardiac Catheterization medicine.medical_specialty Mitral regurgitation High risk patients business.industry MitraClip Mitral Valve Insufficiency Treatment options General Medicine Surgical risk Review article Food and drug administration Treatment Outcome medicine Humans Mitral Valve Cardiac Surgical Procedures Cardiology and Cardiovascular Medicine Intensive care medicine business Functional mitral regurgitation Algorithms |
| Zdroj: | Cardiology in Review. 30:299-307 |
| ISSN: | 1061-5377 |
| Popis: | Over the last decade multiple transcatheter mitral valve repair and replacement strategies have emerged, yet there is only one US Food and Drug Administration approved device, the MitraClip (Abbott Vascular, Inc., Santa Clara, California). Current guidelines support the use of the MitraClip in high or prohibitive surgical risk patients, but there are many patients that are not anatomically suited for the device. This review article discusses the approach to degenerative and functional mitral regurgitation in the high-prohibitive risk patient, how to choose transcatheter treatment options (both approved and investigational), and potential management for therapy failure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|